Aquestive TherapeuticsAQST
那斯達克 · USD
4.78
-0.21
(-4.21%)
收盤 09/12 03:59 (UTC+8)
盤後
4.75
4.75
(-0.63%)
09/12 03:59 (UTC+8)
Aquestive TherapeuticsAQST
4.78
-0.21
(-4.21%)
財務數據
損益表
- 0.12
- 0.20
- 0.14
- 0.12
- 0.09
- 0.10
- 0.13
- 0.13
- 0.14
- 0.14
- -8.73
- 66.76
- -32.62
- -12.37
- -26.52
- 14.71
- 28.03
- 1.62
- 11.00
- -4.34
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 13,819 | 14,446 | 13,015 | 12,807 | 10,003 | 8,720 | 11,867 | 13,542 | 20,099 | 12,053 |
營業成本 | 4,017 | 3,469 | 5,836 | 4,506 | 4,561 | 3,652 | 4,520 | 4,437 | 4,526 | 4,389 |
營業毛利 | 9,802 | 10,977 | 7,179 | 8,301 | 5,442 | 5,068 | 7,347 | 9,105 | 15,573 | 7,664 |
營業費用 | 18,025 | 15,181 | 36,018 | 19,780 | 16,810 | - | - | - | - | - |
研發費用 | 3,962 | 4,204 | 3,196 | 4,530 | 4,105 | 5,361 | 4,917 | 5,269 | 4,162 | 5,932 |
推銷及管理費用 | 14,063 | 10,977 | 32,822 | 15,250 | 12,705 | 19,072 | 16,009 | 12,126 | 11,356 | 10,689 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -8,223 | -4,204 | -28,839 | -11,479 | -11,368 | -19,365 | -13,579 | -8,290 | 55 | -8,957 |
其他收入及費用 | -10,801 | 83 | 1,252 | 306 | 2,096 | 713 | 734 | 979 | 1,395 | 329 |
利息費用 | 3,840 | 3,936 | 4,273 | 4,273 | 4,276 | 4,278 | 4,224 | 4,198 | 4,195 | 4,200 |
稅前純益 | -22,864 | -8,057 | -31,860 | -15,446 | -13,548 | -22,930 | -17,069 | -11,509 | -2,745 | -12,828 |
所得稅 | - | - | - | - | - | - | -14 | - | - | - |
稅後純益 | -22,864 | -8,057 | -31,860 | -15,446 | -13,548 | -22,930 | -17,055 | -11,509 | -2,745 | -12,828 |
基本每股稅後盈餘(元) | -0.18 | -0.07 | -0.26 | -0.14 | -0.14 | -0.24 | -0.19 | -0.13 | -0.03 | -0.17 |
稀釋每股稅後盈餘(元) | -0.18 | -0.07 | -0.27 | -0.14 | -0.13 | -0.24 | -0.19 | -0.13 | -0.02 | -0.17 |
基本平均股數(千股) | 124994.00 | 122609.00 | 121966.00 | 110584.00 | 99326.00 | 95497.00 | 91199.00 | 91082.00 | 90911.00 | 73614.00 |
稀釋平均股數(千股) | 124994.00 | 122609.00 | 121966.00 | 110584.00 | 99326.00 | 95497.00 | 91199.00 | 91082.00 | 90911.00 | 73614.00 |
還原基本每股稅後盈餘(元) | -0.18 | -0.07 | -0.26 | -0.14 | -0.14 | -0.24 | -0.19 | -0.13 | -0.03 | -0.17 |
還原稀釋每股稅後盈餘(元) | -0.18 | -0.07 | -0.27 | -0.14 | -0.13 | -0.24 | -0.19 | -0.13 | -0.02 | -0.17 |
還原基本平均股數(千股) | 124,994 | 122,609 | 121,966 | 110,584 | 99,326 | 95,497 | 91,199 | 91,082 | 90,911 | 73,614 |
還原稀釋平均股數(千股) | 124,994 | 122,609 | 121,966 | 110,584 | 99,326 | 95,497 | 91,199 | 91,082 | 90,911 | 73,614 |
EBITDA(千元) | -17,121 | -1,722 | -24,708 | -8,286 | -6,384 | -15,763 | -9,999 | -4,479 | 4,324 | -5,748 |